Table 1 Baseline characteristics of participants stratified by metabolic syndrome status in the UK Biobank cohort
Characteristics | Non-metabolic syndrome (N = 354 625) | Metabolic syndrome (N = 112 163) | Overall (N = 466 788) |
|---|---|---|---|
Mean (SD) age, years | 56.2 (8.2) | 58.5 (7.7) | 56.8 (8.1) |
Female, N (%) | 194,126 (54.7) | 56,185 (50.1) | 250,311 (53.6) |
White, N (%) | 334,812 (94.4) | 106,066 (94.6) | 440,878 (94.4) |
Mean (SD), index of multiple deprivation | 16.6 (13.6) | 19.6 (15.3) | 17.3 (14.1) |
Never smoker | 201,094 (56.7) | 54,663 (48.7) | 255,757 (54.8) |
Never drinker | 25,588 (7.2) | 11,765 (10.5) | 37,353 (8.0) |
> 5 portions of fruit and vegetable per day, N (%) | 135,273 (38.1) | 40,167 (35.8) | 175,440 (37.6) |
High activity, N (%) | 122,911 (34.7) | 28,614 (25.5) | 151,525 (32.5) |
Multivitamin use, N (%) | 53,834 (15.2) | 15,467 (13.8) | 69,301 (14.8) |
Intake of mineral supplements, N (%) | 77,332 (21.8) | 21,972 (19.6) | 99,304 (21.3) |
Aspirin use, N (%) | 38,800 (10.9) | 27,687 (24.7) | 66,487 (14.2) |
Non-aspirin NSAIDs use, N (%) | 56,495 (15.9) | 19,592 (17.5) | 76,087 (16.3) |
History of Alzheimer’s disease/dementia | 41,322 (11.7) | 12,983 (11.6) | 54,305 (11.6) |
Mean (SD) waist circumference, cm | 86.0 (11.1) | 104 (10.8) | 90.3 (13.5) |
Mean (SD) BMI, kg/m2 | 25.9 (3.71) | 32.4 (4.4) | 27.4 (4.8) |
Mean (SD) TG, mmol/L | 1.52 (0.9) | 2.40 (1.2) | 1.74 (1.0) |
Mean (SD) HDL, mmol/L | 1.52 (0.4) | 1.23 (0.3) | 1.45 (0.4) |
Mean (SD) LDL, mmol/L | 3.56 (0.8) | 3.53 (1.0) | 3.55 (0.867) |
Mean (SD) cholesterol, mmol/L | 5.73 (1.1) | 5.57 (1.3) | 5.69 (1.1) |
Mean (SD) fasting glucose, mmol/L | 4.97 (0.9) | 5.54 (1.8) | 5.12 (1.2) |
Mean (SD) HbA1c, mmol/L | 35.1 (5.2) | 39.3 (9.6) | 36.1 (6.8) |
Mean (SD) SBP, mmHg | 138 (19.7) | 146 (18.0) | 140 (19.7) |
Mean (SD) DBP, mmHg | 81.1 (10.6) | 86.0 (10.3) | 82.3 (10.7) |